On the other hand, SETDB1 inhibits ERV expression through H3K9 methylation to prevent ERV-induced B cell immune response, thereby enabling acute myeloid leukemia (AML) cells to evade innate immunity (Cuellar et al., 2017). This evidence concerns the gene SETDB1 and acute myeloid leukemia.